LPS-induced effects on angiotensin I-converting enzyme expression and shedding in human pulmonary microvascular endothelial cells

In Vitro Cellular and Developmental Biology - Animal

Volumn 50, Issue 4, 2014, Pages 287-295

  Hermanns, M I ^a   Muller A M ^b   Tsokos, M ^c   Kirkpatrick, C J ^d  

^a IKFE CRO GmbH   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

ACE; Angiotensin converting enzyme; CD143 shedding; Human pulmonary microvascular endothelial cells; Lung tissue

Indexed keywords

ESCHERICHIA COLI;

DIPEPTIDYL CARBOXYPEPTIDASE; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN;

BIOSYNTHESIS; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG; UMBILICAL VEIN ENDOTHELIAL CELL;

ENDOTHELIAL CELLS; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPOLYSACCHARIDES; LUNG; MEMBRANE PROTEINS; PEPTIDYL-DIPEPTIDASE A;

EID: 84898599424     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-013-9707-0     Document Type: Article

References (42)

1. Aird W. C. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 100: 174-90; 2007.
2. Annane D.; Bellissant E.; Cavaillon J. M. Septic shock. Lancet 365: 63-78; 2005.
3. Atochina E. N.; Hiemisch H. H.; Muzykantov V. R.; Danilov S. M. Systemic administration of platelet-activating factor in rat reduces specific pulmonary uptake of circulating monoclonal antibody to angiotensin-converting enzyme. Lung 170: 349-58; 1992.
4. Atochina E. N.; Muzykantov V. R.; Al-Mehdi A. B.; Danilov S. M.; Fisher A. B. Normoxic Lung Ischemia/Reperfusion Accelerates Shedding of Angiotensin Converting Enzyme from the Pulmonary Endothelium. Am. J. Respir. Crit. Care Med. 156: 1114-1119; 1997.
5. Balyasnikova I. V.; Danilov S. M.; Muzykantov V. R.; Fisher A. B. Modulation of angiotensin-converting enzyme in cultured human vascular endothelial cells. In Vitro Cell. Dev. Biol. Anim. 34: 545-54; 1998.
6. Cookson W. O.; Wiseman M. S.; Shale D. J. Angiotensin converting enzyme and endotoxin induced lung damage in the mouse. Thorax 40: 774-7; 1985.
7. Cziraki A.; Horvath I. G.; Papp L. Endothelial function studies in pulmonary vascular disease: determination of angiotensin converting enzyme activity in humans (review). Int. J. Mol. Med. 9: 317-25; 2002.
8. Danilov S.; Atochina E.; Hiemisch H.; Churak-ova T.; Moldobayeva A.; Sakharov I. et al. Interaction of mAb to angiotensin-converting enzyme (ACE) with antigen in vitro and in vivo: antibody targeting to the lung induces ACE antigenic modulation. Int. Immunol. 6: 1153-60; 1994.
9. Ehlers M. R.; Gordon K.; Schwager S. L.; Sturrock E. D. Shedding the load of hypertension: the proteolytic processing of angiotensin-converting enzyme. S. Afr. Med. J. 102: 461-4; 2012.
10. English W. R.; Corvol P.; Murphy G. LPS activates ADAM9 dependent shedding of ACE from endothelial cells. Biochem. Biophys. Res. Commun. 421: 70-5; 2012.
11. Fourrier F.; Chopin C.; Wallaert B.; Mazurier C.; Mangalaboyi J.; Durocher A. Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDS. Chest 87: 191-5; 1985.
12. Friedland J.; Silverstein E. A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am. J. Clin. Pathol. 66: 416-24; 1976.
13. Gorin A. B.; Hasagawa G.; Hollinger M.; Sperry J.; Zuckerman J. Release of angiotensin converting enzyme by the lung after Pseudomonas bacteremia in sheep. J. Clin. Invest. 68: 163-70; 1981.
14. Hagiwara S.; Iwasaka H.; Matumoto S.; Hidaka S.; Noguchi T. Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models. Crit. Care Med. 37: 626-33; 2009.
15. He X.; Han B.; Mura M.; Xia S.; Wang S.; Ma T. et al. Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats. Shock 28: 106-11; 2007.
16. Hollinger M. A. Effect of endotoxin on mouse serum angiotensin-converting enzyme. Am. Rev. Respir. Dis. 127: 756-7; 1983.
17. Hooper N. M.; Karran E. H.; Turner A. J. Membrane protein secretases. Biochem. J. 321(Pt 2): 265-79; 1997.
18. Jaffe E. A.; Nachman R. L.; Becker C. G.; Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52: 2745-56; 1973.
19. Jerng J. S.; Hsu Y. C.; Wu H. D.; Pan H. Z.; Wang H. C.; Shun C. T. et al. Role of the renin-angiotensin system in ventilator-induced lung injury: an in vivo study in a rat model. Thorax 62: 527-35; 2007.
20. Johnson A. R.; Coalson J. J.; Ashton J.; Larumbide M.; Erdos E. G. Neutral endopeptidase in serum samples from patients with adult respiratory distress syndrome. Comparison with angiotensin-converting enzyme. Am. Rev. Respir. Dis. 132: 1262-7; 1985.
21. Kelley J. Lavage angiotensin-converting enzyme as a marker of lung injury. Am. Rev. Respir. Dis. 137: 531-4; 1988.
22. Levy M. M.; Fink M. P.; Marshall J. C.; Abraham E.; Angus D.; Cook D. et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31: 1250-6; 2003.
23. Marshall R. P.; Webb S.; Bellingan G. J.; Montgomery H. E.; Chaudhari B.; McAnulty R. J. et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 166: 646-50; 2002.
24. Metzger R.; Franke F. E.; Bohle R. M.; Alhenc-Gelas F.; Danilov S. M. Heterogeneous distribution of angiotensin I-converting enzyme (CD143) in the human and rat vascular systems: vessel, organ and species specificity. Microvasc. Res. 81: 206-15; 2011.
25. Muller A. M.; Gruhn K.; Lange S.; Franke F. E.; Muller K. M. Angiotensin converting enzyme (ACE, CD143) in the regular pulmonary vasculature. Pathologe 25: 141-6; 2004.
26. Muzykantov V. R.; Puchnina E. A.; Atochina E. N.; Hiemish H.; Slinkin M. A.; Meertsuk F. E. et al. Endotoxin reduces specific pulmonary uptake of radiolabeled monoclonal antibody to angiotensin-converting enzyme. J. Nucl. Med. 32: 453-60; 1991.
27. Nukiwa T.; Matsuoka R.; Takagi H.; Ishii Y.; Arai T.; Kira S. Responses of serum and lung angiotensin-converting enzyme activities in the early phase of pulmonary damage induced by oleic acid in dogs. Am. Rev. Respir. Dis. 126: 1080-6; 1982.
28. Orfanos S. E.; Armaganidis A.; Glynos C.; Psevdi E.; Kaltsas P.; Sarafidou P. et al. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation 102: 2011-8; 2000.
29. Orfanos S. E.; Chen X. L.; Ryan J. W.; Chung A. Y.; Burch S. E.; Catravas J. D. Assay of pulmonary microvascular endothelial angiotensin-converting enzyme in vivo: comparison of three probes. Toxicol. Appl. Pharmacol. 124: 99-111; 1994.
30. Orfanos S. E.; Ehrhart I. C.; Barman S.; Hofman W. F.; Catravas J. D. Endothelial ectoenzyme assays estimate perfused capillary surface area in the dog lung. Microvasc. Res. 54: 145-55; 1997.
31. Orfanos S. E.; Langleben D.; Khoury J.; Schlesinger R. D.; Dragatakis L.; Roussos C. et al. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans. Circulation 99: 1593-9; 1999.
32. Remmele W.; Schicketanz K. H. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol. Res. Pract. 189: 862-6; 1993.
33. Rubenfeld G. D.; Caldwell E.; Peabody E.; Weaver J.; Martin D. P.; Neff M. et al. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353: 1685-93; 2005.
34. Siefkin A. D.; Parsons G. H.; Patwell S. W.; Hollinger M. A. The value of serial serum angiotensin converting enzyme determinations in hospitalized patients with lung disease. Am. J. Med. Sci. 288: 200-7; 1984.
35. Simionescu M. Ultrastructural organization of the alveolar-capillary unit. Ciba. Found. Symp. 78: 11-36; 1980.
36. Villard E.; Alonso A.; Agrapart M.; Challah M.; Soubrier F. Induction of angiotensin I-converting enzyme transcription by a protein kinase C-dependent mechanism in human endothelial cells. J. Biol. Chem. 273: 25191-7; 1998.
37. Votta-Velis E. G.; Minshall R. D.; Visintine D. J.; Castellon M.; Balyasnikova I. V. Propofol Attenuates Endotoxin-Induced Endothelial Cell Injury, Angiotensin-Converting Enzyme Shedding, and Lung Edema. Anesth. Analg. 105: 1363-1370; 2007.
38. Wagner M.; Hermanns I.; Bittinger F.; Kirkpatrick C. J. Induction of stress proteins in human endothelial cells by heavy metal ions and heat shock. Am. J. Physiol. 277: L1026-33; 1999.
39. Ware L. B.; Matthay M. A. The acute respiratory distress syndrome. N. Engl. J. Med. 342: 1334-49; 2000.
40. Watanabe K.; Jaffe E. A. Comparison of the potency of various serotypes of E. coli lipopolysaccharides in stimulating PGI2 production and suppressing ACE activity in cultured human umbilical vein endothelial cells. Prostaglandins Leukot Essent Fatty Acids 49: 955-8; 1993.
41. Watanabe K.; Lam G.; Keresztes R. S.; Jaffe E. A. Lipopolysaccharides decrease angiotensin converting enzyme activity expressed by cultured human endothelial cells. J. Cell. Physiol. 150: 433-9; 1992.
42. Wosten-van Asperen R. M.; Lutter R.; Specht P. A.; van Woensel J. B.; van der Loos C. M.; Florquin S. et al. Ventilator-induced inflammatory response in lipopolysaccharide-exposed rat lung is mediated by angiotensin-converting enzyme. Am. J. Pathol. 176: 2219-27; 2010.